National Lipid Association

 

National Lipid Association
Avatar

Management of Atherogenic Dyslipidemia and Atherosclerosis: What Are PPARs? Is Pemafibrate Efficient and Safe to Use?

By National Lipid Association FEATURING Savitha Subramanian
By National Lipid Association FEATURING Savitha Subramanian
221 views
March 19, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

05:11
Novartis Cardiology

Initiating and Monitoring Patients on a Non-Statin Lipid-Lowering Th…

Feat. R. Sugumaran, P. Shah, S. Shugg

Featured Video

48:22
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch
Session I: Drugs in the Pipeline
15:45

Management of Atherogenic Dyslipidemia and Atherosclerosis: What Are…

National Lipid Association

S. Subramanian

221 views
14:44

Bempedoic Acid: Mechanism of Action, Effects and Potential Uses

National Lipid Association

A. Goldberg

846 views
16:18

ASCVD Therapy Update: Can Inclisiran Improve Adherence and Change Pr…

National Lipid Association

C. Ballantyne

785 views
17:56

Update on Evinacumab: ANGPTL3 and Lipid Management

National Lipid Association

P. Duell

796 views
47:06

Session I Speakers Panel and Q&A

National Lipid Association